Merck's respiratory syncytial virus (RSV) shot was approved even though 11.71% of babies in test trials experienced serious side effects.
Share this post
FDA Approves Merck RSV Shot for Infants …
Share this post
Merck's respiratory syncytial virus (RSV) shot was approved even though 11.71% of babies in test trials experienced serious side effects.